Analytics–Powered Approach to Patient Recruitment Enhances Endpoint Data Quality
In a groundbreaking Phase III psychiatry trial, a pharmaceutical company partnered with Signant to revolutionize patient recruitment through data-driven site selection using PureSignal Analytics.
This innovative approach moved beyond traditional recruitment metrics focused on speed and capacity, instead leveraging real-time analytics to identify and prioritize sites demonstrating the highest quality clinician ratings across 45+ sites in 2 countries.
The results? Enhanced endpoint data quality, optimized signal detection potential, and successful trial completion with 500+ patients enrolled strategically at top-performing sites.
The approach also helped validate the use of analytics-powered recruitment strategies in psychiatry clinical research, proving that data quality can be prioritized without sacrificing enrollment efficiency.
Discover how Signant's PureSignal Analytics solution enabled systematic site performance evaluation, implemented gated recruitment processes, and transformed traditional recruitment approaches to deliver superior endpoint reliability.
